Identification of highly conserved Trypanosoma cruzi antigens for the development of a universal serological diagnostic assay

References

• Chagas disease (American trypanosomiasis) [Fact Sheet]. World Health Organization (WHO); 2021 [updated 2021 Apr]. Available from: https://www.who.int/news-room/fact-sheets/detail/Chagas-disease-(american-trypanosomiasis)
   Google Scholar
• Lee BY, Bacon KM, Bottazzi ME, et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13(4):342–348. doi:10.1016/S1473-3099(13)70002-1
   PubMed Web of Science ®Google Scholar
• Zingales B, Andrade SG, Briones MR, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009;104(7):1051–1054. doi:10.1590/S0074-02762009000700021
   PubMed Web of Science ®Google Scholar
• Marcili A, Lima L, Cavazzana M, et al. A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA. Parasitology. 2009;136(6):641–655. doi:10.1017/S0031182009005861
   PubMed Web of Science ®Google Scholar
• Perez CJ, Lymbery AJ, Thompson RC. Chagas disease: the challenge of polyparasitism? Trends Parasitol. 2014;30(4):176–182. doi:10.1016/j.pt.2014.01.008
   PubMed Web of Science ®Google Scholar
• Sánchez-Camargo CL, Albajar-Viñas P, Wilkins PP, et al. Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in Serum Banks in areas of endemicity and nonendemicity. 2014.
   Google Scholar
• Bartsch SM, Avelis CM, Asti L, et al. The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission. PLoS Negl Trop Dis. 2018;12(11):e0006809. doi:10.1371/journal.pntd.0006809
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Gamboa-León MR, del Cid-Lemus J, et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and México. Am J Trop Med Hyg. 2008;79(5):755–759. doi:10.4269/ajtmh.2008.79.755
   PubMed Web of Science ®Google Scholar
• Guzman-Gomez D, Lopez-Monteon A, de la Soledad Lagunes-Castro M, et al. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic. Parasit Vectors. 2015;8:466. doi:10.1186/s13071-015-1072-2
   PubMed Web of Science ®Google Scholar
• Whitman JD, Bulman CA, Gunderson EL, et al. Chagas disease serological test performance in U.S. blood donor specimens. J Clin Microbiol. 2019;57(12):e01217–19. doi:10.1128/JCM.01217-19
   PubMed Web of Science ®Google Scholar
• Kelly EA, Bulman CA, Gunderson EL, et al. Comparative performance of latest-generation and FDA-cleared serology tests for the diagnosis of Chagas disease. J Clin Microbiol. 2021;59(6):e00158–21. doi:10.1128/JCM.00158-21
   PubMed Web of Science ®Google Scholar
• Truyens C, Dumonteil E, Alger J, et al. Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection. J Clin Microbiol. 2021: JCM0106221.
   Web of Science ®Google Scholar
• Verani JR, Seitz A, Gilman RH, et al. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg. 2009;80(3):410–415. doi:10.4269/ajtmh.2009.80.410
   PubMed Web of Science ®Google Scholar
• Eguez KE, Alonso-Padilla J, Teran C, et al. Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis. PLoS Negl Trop Dis. 2017;11(4):e0005501. doi:10.1371/journal.pntd.0005501
   PubMed Web of Science ®Google Scholar
• Castro-Sesquen YE, Saldana A, Patino Nava D, et al. Evaluation of 2 lateral flow rapid tests in the diagnosis of Chagas disease in the Washington Metropolitan Area. Open Forum Infect Dis. 2021;8(4):ofab096.
   PubMed Web of Science ®Google Scholar
• Mita-Mendoza NK, McMahon E, Kenneson A, et al. Chagas disease in southern Coastal Ecuador: coinfections with arboviruses and a comparison of serological assays for Chagas disease diagnosis. Am J Trop Med Hyg. 2018;99(6):1530–1533. doi:10.4269/ajtmh.18-0441
   PubMed Web of Science ®Google Scholar
• Talavera-López C, Messenger LA, Lewis MD, et al. Repeat-driven generation of antigenic diversity in a major human pathogen Trypanosoma cruzi. bioRxiv [Internet]. 2018.
   Google Scholar
• Llewellyn MS, Miles MA, Carrasco HJ, et al. Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLoS Pathog. 2009;5(5):e1000410. doi:10.1371/journal.ppat.1000410
   PubMed Web of Science ®Google Scholar
• Majeau A, Murphy L, Herrera C, et al. Assessing Trypanosoma cruzi parasite diversity through comparative genomics: implications for disease epidemiology and diagnostics. Pathogens. 2021;10:212. doi:10.3390/pathogens10020212
   PubMed Web of Science ®Google Scholar
• Roellig DM, Savage MY, Fujita AW, et al. Genetic variation and exchange in Trypanosoma cruzi isolates from the United States. PLoS One. 2013;8(2):e56198. doi:10.1371/journal.pone.0056198
   PubMed Web of Science ®Google Scholar
• Llewellyn MS, Lewis MD, Acosta N, et al. Trypanosoma cruzi IIc: phylogenetic and phylogeographic insights from sequence and microsatellite analysis and potential impact on emergent Chagas disease. PLoS Negl Trop Dis. 2009;3(9):e510. doi:10.1371/journal.pntd.0000510
   PubMed Web of Science ®Google Scholar
• Schwabl P, Maiguashca Sánchez J, Costales JA, et al. Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity. PLoS Genet. 2020;16(12):e1009170. doi:10.1371/journal.pgen.1009170
   PubMed Web of Science ®Google Scholar
• Reis-Cunha JL, Baptista RP, Rodrigues-Luiz GF, et al. Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU. BMC Genom. 2018;19(1):816. doi:10.1186/s12864-018-5198-4
   PubMed Web of Science ®Google Scholar
• Gruber A, Zingales B. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas’ disease. Exp Parasitol. 1993;76(1):1–12. doi:10.1006/expr.1993.1001
   PubMed Web of Science ®Google Scholar
• Carmona SJ, Nielsen M, Schafer-Nielsen C, et al. Towards high-throughput immunomics for infectious diseases: use of next-generation peptide microarrays for rapid discovery and mapping of antigenic determinants. Mol Cell Proteomics. 2015;14(7):1871–1884. doi:10.1074/mcp.M114.045906
   PubMed Web of Science ®Google Scholar
• Buekens P, Cafferata ML, Alger J, et al. Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: an observational prospective study. Am J Trop Med Hyg. 2018;98(2):478–485. doi:10.4269/ajtmh.17-0516
   PubMed Web of Science ®Google Scholar
• Elmayan A, Tu W, Duhon B, et al. High prevalence of Trypanosoma cruzi infection in shelter dogs from southern Louisiana, USA. Parasit Vectors. 2019;12(1):322. doi:10.1186/s13071-019-3572-y
   PubMedGoogle Scholar
• Sanchez B, Monteon V, Reyes PA, et al. Standardization of micro-enzymes-linked immunosorbent assay (ELISA) and western blot for detection of Trypanosoma cruzi antibodies using extracts from mexican strains as antigens. Arch Med Res. 2001;32:382–388. doi:10.1016/S0188-4409(01)00303-4
   PubMed Web of Science ®Google Scholar
• Gamboa-Leon R, Gonzalez-Ramirez C, Padilla-Raygoza N, et al. Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns? J Parasitol. 2011;97(2):338–343. doi:10.1645/GE-2545.1
   PubMed Web of Science ®Google Scholar
• Ricci AD, Bracco L, Salas-Sarduy E, et al. The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas. Nat Commun. 2023;14(1):1850. doi:10.1038/s41467-023-37522-9
   PubMed Web of Science ®Google Scholar
• Kamath K, Reifert J, Johnston T, et al. Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology. Sci Rep. 2020;10(1):5294. doi:10.1038/s41598-020-62256-9
   PubMed Web of Science ®Google Scholar
• Mucci J, Carmona SJ, Volcovich R, et al. Next-generation ELISA diagnostic assay for Chagas disease based on the combination of short peptidic epitopes. PLoS Negl Trop Dis. 2017;11(10):e0005972. doi:10.1371/journal.pntd.0005972
   PubMed Web of Science ®Google Scholar
• Santos FL, Celedon PA, Zanchin NI, et al. Performance assessment of four chimeric Trypanosoma cruzi Antigens based on antigen-antibody detection for diagnosis of chronic Chagas disease. PLoS One. 2016;11(8):e0161100. doi:10.1371/journal.pone.0161100
   PubMed Web of Science ®Google Scholar
• Otani MM, Vinelli E, Kirchhoff LV, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009;49(6):1076–1082.
   PubMed Web of Science ®Google Scholar
• Darling AE, Mau B, Perna NT. ProgressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One. 2010;5(6):e11147. doi:10.1371/journal.pone.0011147
   PubMed Web of Science ®Google Scholar
• Majeau A, Murphy L, Herrera C, et al. Assessing Trypanosoma cruzi parasite diversity through comparative genomics: implications for disease epidemiology and diagnostics. Pathogens. 2021;10(2):212. doi:10.3390/pathogens10020212
   PubMed Web of Science ®Google Scholar
• Buekens P, Cafferata ML, Alger J, et al. Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: an observational prospective study. Am J Trop Med Hyg. 2018;98(2):478–485. doi:10.4269/ajtmh.17-0516
   PubMed Web of Science ®Google Scholar
• Moser DR, Kirchhoff LV, Donelson JE. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol. 1989;27(7):1477–1482. doi:10.1128/jcm.27.7.1477-1482.1989
   PubMed Web of Science ®Google Scholar
• Wincker P, Britto C, Pereira JB, et al. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from Chronic Chagasic patients in a rural endemic area. Am J Trop Med Hyg. 1994;51(6):771–777. doi:10.4269/ajtmh.1994.51.771
   PubMed Web of Science ®Google Scholar
• Buekens P, Cafferata ML, Alger J, et al. Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: an observational prospective study. Am J Trop Med Hyg. 2018;98(2):478–485. doi:10.4269/ajtmh.17-0516
   PubMed Web of Science ®Google Scholar
• Truyens C, Dumonteil E, Alger J, et al. Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection. J Clin Microbiol. 2021;59(12):e0106221. doi:10.1128/JCM.01062-21
   PubMed Web of Science ®Google Scholar
• Murphy N, Macchiaverna NP, Victoria Cardinal M, et al. Lineage-specific rapid diagnostic tests can resolve Trypanosoma cruzi TcII/V/VI ecological and epidemiological associations in the Argentine Chaco. Parasit Vectors. 2019;12(1):424. doi:10.1186/s13071-019-3681-7
   PubMed Web of Science ®Google Scholar
• Herrera C, Truyens C, Dumonteil E, et al. Phylogenetic analysis of Trypanosoma cruzi from pregnant women and newborns from Argentina, Honduras and Mexico suggests an association of parasite haplotypes with congenital transmission of the parasite. J Mol Diag. 2019;21(6):1095–1105. doi:10.1016/j.jmoldx.2019.07.004
   PubMed Web of Science ®Google Scholar
• Dent AE, Nakajima R, Liang L, et al. Plasmodium falciparum protein microarray antibody profiles correlate with protection from symptomatic Malaria in Kenya. J Infect Dis. 2015;212(9):1429–1438. doi:10.1093/infdis/jiv224
   PubMed Web of Science ®Google Scholar
• Baum E, Badu K, Molina DM, et al. Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels. PLoS One. 2013;8(12):e82246. doi:10.1371/journal.pone.0082246
   PubMed Web of Science ®Google Scholar
• Mutapi F, Burchmore R, Mduluza T, et al. Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis. 2008;198(2):167–175. doi:10.1086/589511
   PubMed Web of Science ®Google Scholar
• Dendrou CA, Petersen J, Rossjohn J, et al. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325–339. doi:10.1038/nri.2017.143
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Alvarez MG, et al. Impact of aetiological treatment on convenional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis. 2011;5(9):e1314. doi:10.1371/journal.pntd.0001314
   PubMed Web of Science ®Google Scholar
• Jurado Medina L, Chassaing E, Ballering G, et al. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study. Lancet Infect Dis. 2021;21(8):1141–1150. doi:10.1016/S1473-3099(20)30729-5
   PubMed Web of Science ®Google Scholar